Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation ...
Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...
Semiconductor stocks enter 2026 with AI tailwinds but rising risks, narrow leadership, and Fed policy threats. Read here for ...
For Derek ’95 and Amber Walker ’94 Empie, DePauw University is more than a name at the top of their diplomas. It’s the place ...
MedPage Today on MSN
FDA Approves Mitapivat for Thalassemia-Related Anemia
An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...
Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.
Calgary Herald on MSN
Charitable groups in Calgary mobilize to support those in need on Christmas Day
On early Christmas Day morning, several groups in the city were already on the streets, lending a helping hand for the less ...
Morning Overview on MSN
This nuked-pulse rocket could reach Alpha Centauri in 44 years
Reaching Alpha Centauri within a single human lifetime has long sounded like science fiction, yet a new generation of nuclear ...
In a statement, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) said that the FDA officially approved Aqvesme to treat anemia in ...
DUBLIN, Ohio, Dec. 30, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced that reAlpha Mortgage, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback